Cargando…

MON-137 Evaluation of the Timeliness of Serial Denosumab Administrations at the University of Colorado Hospital

BACKGROUND: Denosumab is an antiresorptive medication commonly used in the treatment of osteoporosis that works by slowing bone loss. This medication should not be delayed or interrupted without initiation of an alternative treatment (i.e. bisphosphonates) as studies have shown that this can lead to...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaman, Adnin, Billups, Sarah J, Rothman, Micol S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207499/
http://dx.doi.org/10.1210/jendso/bvaa046.1327